HALOZYME THERAPEUTICS, INC. Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets
HALOZYME THERAPEUTICS, INC. (HALO) had Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets of $12.11 million as of 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Notes › Leases
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets · last filed 2021-08-09
- 2021-06-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $12.11M.
- 2021-03-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $11.65M.
- 2020-12-31: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $11.58M.
- 2020-09-30: Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets $11.79M.
| Period end | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Excluding Capital Leased Assets |
|---|---|
| 2021-06-30 | $12.11M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $11.65M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $11.58M 10-Q · filed 2021-08-09 |
| 2020-09-30 | $11.79M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $11.29M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $10.80M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $10.74M 10-K · filed 2021-02-23 |
| 2019-09-30 | $17.90M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $17.21M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $16.82M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $16.24M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |